Wegovy Pill EU Approval: Impact on Novo Nordisk’s Competitive Edge
The European Commission recently approved the oral version of Wegovy (semaglutide 25 mg) for adults with obesity and at least one weight-related comorbidity, according to Novo Nordisk. This regulatory milestone makes Wegovy the first GLP-1 tablet authorized for weight management in the European Union, following previous approvals in the United States, United Kingdom, United Arab … Read more